From September 1, 2023 to November 30, 2023, the company has repurchased 1,356,000 shares, representing 1.75% for ¥6,806.73 million. With this, the company has completed the repurchase of 1,633,400 shares, representing 2.11% for ¥8,140.32 million under the buyback announced on July 13, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,750 JPY | +0.89% |
|
+1.24% | -13.01% |
06-24 | Hisamitsu Pharmaceutical Co., Inc.(TSE:4530) dropped from S&P Japan Mid Cap 100 | CI |
05-24 | Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on May 23, 2024. | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.01% | 1.69B | |
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+2.04% | 224B | |
+13.31% | 218B | |
+8.48% | 168B |
- Stock Market
- Equities
- 4530 Stock
- News Hisamitsu Pharmaceutical Co., Inc.
- Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.